Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates through two segments, Intermediates and Bulk Medicines; and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, cephalosporin tablets, and other oral solid-dosage-form antibiotics. It also provides system specific medicines comprising cardiovascular systems; anti-HBV, anti-allergic, and digestive systems; urinary systems; anti-hypertensive, antihyperlipidemic, and antiviral; and endocrine system drugs in the form of tablets, capsules, and granules. Dawnrays Pharmaceutical (Holdings) Limited was founded in 1995 and is headquartered in Wan Chai, Hong Kong.
Metrics to compare | 2348 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2348PeersSector | |
---|---|---|---|---|
P/E Ratio | 3.5x | 22.7x | −0.5x | |
PEG Ratio | 0.05 | −0.65 | 0.00 | |
Price/Book | 0.6x | 2.1x | 2.6x | |
Price / LTM Sales | 1.8x | 2.7x | 3.2x | |
Upside (Analyst Target) | - | 0.5% | 42.0% | |
Fair Value Upside | Unlock | 10.9% | 6.6% | Unlock |